The slip
PARKINSON RECEIPTno. 12331
27 Oct 2026, 21:47 UTCdopamine neurons, braak
predictionACOT7 in dopamine neurons tracks Braak Lewy-body stage
registered758ec4f29f8222b3
discovery-0.19 p=0.630 n=9
replication-0.28 p=0.470 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.19, p 0.630)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT081f732e8702d59064abd05f…
follows 2a8bd8a4f38f…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 12331: ACOT7 in dopamine neurons, braak
- power
- full sample -0.21 (p 0.393, n 18), 95% CI -0.62 to +0.28. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.21 (p 0.393, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.37 (p 0.135, n 18). could be the mix.
- skeptic
- leave-one-out range -0.33 to -0.11, sign flips 0; without severely affected donors -0.21 (p 0.393, n 18). fragile.
- cell type
- strongest in oligodendrocytes: -0.77 (p 1.8e-4, n 18) vs -0.21 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ACOT7 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up ACOT7 · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.28 p 0.328 (needs p < 1.8e-4)